Some studies have also shown synergistic anti-cancer effects between TRAIL and HDAC inhibitors.35, 36, 37 Western blot analysis shows that the HDAC inhibitor vorinostat alters death receptor expression in HepG2 cells (Figure 3A). Here, TNFSF10 is linked to cancer.